An earlier report indicated that AR could regulate miR-145 to upregulate HIF2α expression in RCC36, thus it is likely that AR may regulate ccRCC metastatic destinations through a combination of various mechanisms. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.